Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

Sustained cardiac hypertrophy represents one of the most common causes leading to cardiac failure. There is emerging evidence to implicate the involvement of NF-κB in the development of cardiac hypertrophy. However, several critical questions remain unanswered. We tested the use of soluble epoxide h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Xu, Danyan, Li, Ning, He, Yuxia, Timofeyev, Valeriy, Lu, Ling, Tsai, Hsing-Ju, Kim, In-Hae, Tuteja, Dipika, Mateo, Robertino Karlo P., Singapuri, Anil, Davis, Benjamin B., Low, Reginald, Hammock, Bruce D., Chiamvimonvat, Nipavan
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2006
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1693731/
https://ncbi.nlm.nih.gov/pubmed/17130447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0609158103
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars